Acivery has developed a new process for the production of pharmaceutical actives for pulmonary drug. Our technology leads to the precipitation of non-agglomerated crystalline powders with narrow particle size distributions
In Activery we believe that solid state modifications may lead to a critical changes in your active pharmaceutical, thus to a differentiated drug or to a brand new innovative medicine
Activery possess unrivalled specialist expertise about different crystallization techniques and expert knowledge in the field of solid state modulation.
In Activery, we design and produce particles for special uses where size matters such as nanoparticles for cancer treatment. Through our technology you would enable new administration routes or renewed performance of your drug formulation.
 |
 |
 |
Good Manufacturing Practices (GMP) in ActiveryGood Manufacturing Practices or GMP is a must for manufacturing pharmaceutical products such as nanoparticles and microparticles and modified API (Active Pharmaceutical Ingredients). As Activery wants to be a critical player in the pharmaceutical market, soon, Activery will have its own cGMP compliant facilities to provide powders suitable for human clinical trials in Navarra (Spain)
Phone: +34 935 820 152 E-mail: contactus @ activery.com P (Good Manufacturing Practices) Soon, Activery will have its own cGMP compliant facilities to provide powders suitable for human clinical trialsGood Manufacturing Practice or GMP is a must for manufacturing pharmaceutical products such as the particles and modified API (Active Pharmaceutical Ingredients). As Activery wants to be a critical player in the pharmaceutical market, soon, Activery will have its own cGMP compliant facilities to provide powders suitable for human clinical trials in Navarra (Spain)
Phone: +34 935 820 152 E-mail: contactus @ activery.com
|